ECM
TNXP icon

ExodusPoint Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History

ExodusPoint Capital Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Hold
0
– -$239K – 2638
2021
Q2 		– Sell
-1
Closed -$735K – 1885
2021
Q1 		$762K Buy
+1
New +$765K 0.01% 1083

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

ExodusPoint Capital Management's TNXP Position: Q3 2021 in Review

ExodusPoint Capital Management held its Tonix Pharmaceuticals (TNXP) position steady in Q3 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2638.

ExodusPoint Capital Management first reported a position in TNXP in Q1 2021 and has held it in 1 quarter since. The position peaked at $762K in Q1 2021. 18 funds tracked by Wall St. Rank hold TNXP as of Q3 2021.

  • ExodusPoint Capital Management held 0 shares of Tonix Pharmaceuticals worth $0 as of Q3 2021.
  • ExodusPoint Capital Management left its Tonix Pharmaceuticals share count unchanged in Q3 2021.
  • Tonix Pharmaceuticals made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q3 2021, its #2638 holding.
  • ExodusPoint Capital Management first reported a position in Tonix Pharmaceuticals in Q1 2021 and has held it in 1 quarter since.
  • ExodusPoint Capital Management's Tonix Pharmaceuticals position peaked at $762K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.